E Nkenke

Author PubWeight™ 18.06‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Head and neck tumors: imaging recurrent tumor and post-therapeutic changes with CT and MRI. Eur J Radiol 2000 1.24
2 Prognostic role of pretreatment plasma fibrinogen in patients with solid tumors: A systematic review and meta-analysis. Cancer Treat Rev 2015 1.05
3 Radiochemotherapy induces a favourable tumour infiltrating inflammatory cell profile in head and neck cancer. Oral Oncol 2012 1.04
4 Harvesting of bone from the iliac crest--comparison of the anterior and posterior sites. Br J Oral Maxillofac Surg 2005 1.03
5 The interleukin-8 (-251A/T) polymorphism is associated with increased risk for oral squamous cell carcinoma. Eur J Surg Oncol 2006 0.91
6 A metalloproteinase-9 polymorphism which affects its expression is associated with increased risk for oral squamous cell carcinoma. Eur J Surg Oncol 2007 0.90
7 The effect on bone regeneration of a liposomal vector to deliver BMP-2 gene to bone grafts in peri-implant bone defects. Biomaterials 2007 0.89
8 Plasminogen activator inhibitor-1 polymorphism is associated with increased risk for oral cancer. Oral Oncol 2006 0.89
9 Onlay augmentation versus sinuslift procedure in the treatment of the severely resorbed maxilla: a 5-year comparative longitudinal study. Int J Oral Maxillofac Surg 2005 0.86
10 Gene polymorphisms related to angiogenesis, inflammation and thrombosis that influence risk for oral cancer. Oral Oncol 2008 0.84
11 Air gun pellet remaining in the maxillary sinus for 50 years: a relevant risk factor for the patient? Int J Oral Maxillofac Surg 2009 0.83
12 Strong association of interleukin-6 -174 G>C promoter polymorphism with increased risk of oral cancer. Int J Biol Markers 2006 0.83
13 Factors influencing relative speech intelligibility in patients with oral squamous cell carcinoma: a prospective study using automatic, computer-based speech analysis. Int J Oral Maxillofac Surg 2013 0.82
14 Msx-1 is suppressed in bisphosphonate-exposed jaw bone analysis of bone turnover-related cell signalling after bisphosphonate treatment. Oral Dis 2011 0.82
15 The low VEGF production allele of the +936C/T polymorphism is strongly associated with increased risk for oral cancer. J Cancer Res Clin Oncol 2007 0.82
16 Diabetes may increase risk for oral cancer through the insulin receptor substrate-1 and focal adhesion kinase pathway. Oral Oncol 2006 0.80
17 Automatic, computer-based speech assessment on edentulous patients with and without complete dentures - preliminary results. J Oral Rehabil 2010 0.78
18 Diabetes enhances cell proliferation but not Bax/Bcl-2-mediated apoptosis during oral oncogenesis. Int J Oral Maxillofac Surg 2007 0.78
19 Association of platelet glycoprotein Ia polymorphism with minor increase of risk for oral cancer. Eur J Surg Oncol 2006 0.78
20 [Numeric quantification of intelligibility in schoolchildren with isolated and combined cleft palate]. HNO 2007 0.77
21 Prediction of recurrence using exfoliative cytology and melanoma-associated antigen-A mRNA analysis following wide excision of oral squamous cell carcinoma: short report. Cytopathology 2010 0.77
22 Automatic quantification of speech intelligibility of adults with oral squamous cell carcinoma. Folia Phoniatr Logop 2008 0.76
23 Hyperthermia and irradiation of head and neck squamous cancer cells causes migratory profile changes of tumour infiltrating lymphocytes. Int J Hyperthermia 2009 0.76
24 [Computer-assisted orbital floor reconstruction. Use of a CAD/CAM implant with intraoperative contact-free 3D endo- and exophthalmometry]. HNO 2008 0.75
25 Abundance and localization of skeletal muscle-related erbB2 may stimulate tumour growth during initial stages of oral oncogenesis. J Musculoskelet Neuronal Interact 2007 0.75
26 [Enophthalmos correction in complex orbital floor reconstruction : computer-assisted, intraoperative, non-contact, optical 3D support]. Ophthalmologe 2008 0.75
27 [An in-vitro study of the bonding and fracture pattern of light-hardening, fluoride-releasing bonding materials in metal brackets]. Fortschr Kieferorthop 1994 0.75